Subscribe to Newsletter

Business & Regulation

Business & Regulation Business Practice

Man Allegedly Praises Pharmaceutical Companies

| Stephanie Vine

Joe Biden apparently dared say there were “great drug companies out there – except for a couple of opioid outfits.”

Business & Regulation Digital Technologies

Time to Pop It In!

| Timo Heikkilä

Timo Heikkilä COO at Popit, Finland, explains how technology can help boost patient compliance rates.

Business & Regulation Contract Development Services

Eyes on Outsourcing

| Stephanie Vine

Catch up on the biggest trends in outsourcing with our infographic.

Business & Regulation Business Practice

On the Side of Caution

| Sue Springett

Sue Springett, Commercial Manager at Teknomek, explains the importance of health and safety in a solid coroporate social responsibility strategy.

Business & Regulation Supply Chain

A Whole Hog of Problems

| Maryam Mahdi

Six members of the US's congress demand answers from the FDA as the risk of heparin shortages loom.

Business & Regulation Standards & Regulation

Five Steps You Won't Want to Miss When Filing an IND

| Sponsored by Regis

What are the most important things to consider when filing an IND? This infographic, sponsored by Regis, sets out the five key steps to success.

Business & Regulation Technology and Equipment

Staying Connected

| Maryam Mahdi

How can a mobile app help in medical adherence?

Business & Regulation Supply Chain

A Digital Transformation in Supply

| Maryam Mahdi

Maeve Magner explains how digital solutions can improve the supply chains of emerging economies.

Business & Regulation Trends & Forecasts

Redefining Pharma

| James Strachan

Should pharma companies transition from developing, manufacturing and pricing “drugs” to promoting “health”?

Business & Regulation Business Practice

GDUFA 2020

| Stephanie Vine

GDUFA fees for 2020 have been decided – and include a significant drop in the fees for finished dosage facilities.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register